LGALS1 and hepatocellular carcinoma: The findings of the present study demonstrate that the upregulation of Galectin-1 exacerbates resistance to sorafenib-mediated ferroptosis by reducing excessive lipid peroxidation in sorafenib-sensitive HCC cells.